SITAGLIPTIN PHOSPHATE
| Brand name | JANUVIA |
|---|---|
| Active ingredient | SITAGLIPTIN PHOSPHATE |
| Strength | EQ 100MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2006 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7326708*PED | May 2027 | — |
| 7326708 | November 2026 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.